申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0620216A1
公开(公告)日:1994-10-19
A compound of the formula :
wherein
R¹ ishydrogen or lower alkyl,
R² ishydrogen, lower alkyl, halo(lower)alkyl, halogen or lower alkoxy,
R³ and R⁴are each hydrogen, lower alkyl or taken together to form oxo,
R⁵ ishydrogen, halogen, nitro, hydroxy, protected hydroxy, lower alkyl or lower alkoxy optionally substituted with lower alkylamino,
R⁶ ishydrogen, lower alkyl or acyl,
A is
in which the substituents R⁷ to R¹³ and the symbol Y have certain meanings, and pharmaceutically accetable salts thereof, and processes for preparing them, and pharmaceutical compositions comprising them as an active ingredient.
式中的化合物:
式中
R¹ 是氢或低级烷基、
R² 是氢、低级烷基、卤代(低级)烷基、卤素或低级烷氧基、
R³ 和 R⁴ 分别为氢、低级烷基或合在一起形成氧代、
R⁵ 是氢、卤素、硝基、羟基、受保护的羟基、低级烷基或可选择被低级烷基氨基取代的低级烷氧基、
R⁶ 是氢、低级烷基或酰基、
A 是
其中取代基 R⁷ 至 R¹³ 和符号 Y 具有特定含义,以及它们的可药用盐、它们的制备方法和包含它们作为活性成分的药物组合物。